A Phase 1, Open-Label (JYNNEOS), Double-Blind (TPOXX And Placebo), Multicenter, Randomized, Placebo-Controlled, Drug-Vaccine Interaction Study To Evaluate the Impact of TPOXX on JYNNEOS Immunogenicity
Latest Information Update: 27 Sep 2024
At a glance
- Drugs Tecovirimat (Primary) ; Modified vaccinia Ankara
- Indications Smallpox; Vaccinia virus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors SIGA Technologies
- 19 Sep 2024 Planned End Date changed from 1 May 2025 to 1 Jul 2025.
- 19 Sep 2024 Planned End Date changed from 5 May 2023 to 1 May 2025.
- 19 Sep 2024 Planned primary completion date changed from 1 May 2023 to 1 May 2025.